Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

32.01
-0.0600-0.19%
Post-market: 32.200.1900+0.59%19:59 EDT
Volume:3.39M
Turnover:109.42M
Market Cap:3.60B
PE:-27.76
High:33.16
Open:32.16
Low:31.28
Close:32.07
Loading ...
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 06, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 05, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 05, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 10, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Aug 02, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 02, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Aug 01, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 01, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 02, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 02, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Jul 02, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
May 23, 2019

Major Issues Report

Current report, item 5.07
May 02, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 02, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 13, 2018

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Jul 17, 2018

Correspondence

Jan 11, 2018

Correspondence

Jan 09, 2018

[Amend]Public Prospectus

维京疗法公司。